Nov 1, 2025
Cymbalta (Duloxetine) vs Alternatives: What Works Best for Depression, Anxiety, and Chronic Pain
Biosimilars offer major cost savings over brand-name biologics, but insurance barriers like prior authorization and same-tier placement make them hard to access. Patients pay nearly the same out-of-pocket costs - defeating the purpose.